Moderna’s COVID-19 vaccine candidate moves into late-stage trial

The race to find a coronavirus vaccine is heating up, with US pharmaceutical company Moderna announcing that its candidate has entered late-stage clinical trials.
That is the final hurdle before it can be approved.
It is being tested on 30,000 volunteers, and there are hopes it will be ready for widespread use by the end of the year.

Al Jazeera’s Heidi Zhou-Castro reports from the US state of Maryland.

– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/

#UScoronavirus #COVID19Vaccine #Moderna


About This Source - Al Jazeera English

The video item below is a piece of English language content from Al Jazeera. Al Jazeera is a Qatari state-funded broadcaster based in Doha, Qatar, owned by the Al Jazeera Media Network.

Recent from Al Jazeera English:

Can international justice stop israel? | inside story 1

Can international justice stop Israel? | Inside Story

A prolonged dry spell across the Indian-administered Kashmir

US march for life: Abortion rights likely issue in Nov election

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

Global National: Jan. 19, 2024 | Health data shows influenza, COVID-19 cases decreasing in Canada

Stock market today: Dow, S&P 500 hit record highs as tech stocks soar | January 19, 2024

Stock market today: Stocks climb with techs ready to roar | January 19, 2023

Dr Anthony Fauci ‘became part of the problem’ when it came to the spread of Covid misinformation

WEF summit: Canada warns of future supply shocks amid global instability

In This Story: Moderna

Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

CEO: Stéphane Bancel (2011–)

Stock ticker: (NASDAQ:MRNA)

5 Recent Items: Moderna

Vaccines: There’s ‘so much noise’ around facts: Moderna CEO

Lightning Round: I’d back Moderna here, says Jim Cramer

Bloomberg Surveillance 01/16/2024

Moderna stock upgraded to outperform by Oppenheimer & Co

Bull market bargain hunting: Why investors should look at Moderna, Nike, and Walgreens

In This Story: Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.

9 Recent Items: Vaccine

‘National incident’ declared over measles outbreak

Southern Africa cholera outbreak: Zambia and Zimbabwe lead vaccine drives

People born 1998-2004 ‘should get measles vaccine’ #measles #vaccine

N.Y. midwife falsified thousands of vaccine records

Vaccines: There’s ‘so much noise’ around facts: Moderna CEO

Vaccine for RSV approved in Australia | 9 News Australia

IT’S OVER! This Fauci SCANDAL Is Just The Tip Of The Iceberg

‘Lunatics have taken over!’ | Neil Oliver on air strikes in Yemen, Britain’s borders and more

They KNEW This Vaccine Data Was TRUE But CENSORED It Anyway!!

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.